ARVO 2017 making global connections in vision research
Though the year is quickly winding down, clinical education opportunities still abound for clinicians and vision researchers via the Association for Research in Vision and Ophthalmology (ARVO). For instance, a one-day public workshop will focus on the newest clinical data on inherited retinal diseases and future clinical trial designs aimed at developing therapies to stem vision loss.
ARVO View By Katrina Norfleet
Though the year is quickly winding down, clinical education opportunities still abound for clinicians and vision researchers via the Association for Research in Vision and Ophthalmology (ARVO).
For instance, a one-day public workshop will focus on the newest clinical data on inherited retinal diseases and future clinical trial designs aimed at developing therapies to stem vision loss.
Organized by ARVO, the NEI/FDA Workshop on “Retinal Disease Clinical Trial Endpoints: AMD and Inherited Retinal Diseases” will take place Nov. 9 on the NIH campus, Bethesda, MD.
Onsite space is limited, however, attendees can still participate via the webcast, which will allow them to view and listen to the lectures and moderated sessions, as well as join online discussions and pose questions.
Participants will review clinical trial design considerations for AMD and inherited retinal diseases in order to develop strategies for:
- Improved trial design and endpoints based on current evidence
- Approaches to classifying and stratifying the patient population
- Clinically meaningful surrogate or interim endpoints
- Potentially impactful gaps for research funding
To learn more or register for the webcast, visit